This topic contains a solution. Click here to go to the answer

Author Question: Define internal validity in research design. Describe two threats to the internal validity of a ... (Read 198 times)

bucstennis@aim.com

  • Hero Member
  • *****
  • Posts: 532
Define internal validity in research design. Describe two threats to the internal validity of a research study. (Note: For each threat, be sure to label it, describe it, and be sure to indicate how it specifically is a threat to the internal validity of the design.)
 
  What will be an ideal response?

Question 2

The group you wish to generalize to is the ____.
 
  a. sample
 b. population
 c. theoretical population
  d. accessible population



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

laurnthompson

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

Internal validity is the degree to which a study allows only one, unambiguous explanation for the results. Threats to internal validity include environmental factors, assignment bias, or any threat specific for studies comparing one group over time. In each case, the threat provides an alternative explanation for any differences that are found between the treatment conditions.

Answer to Question 2

b




bucstennis@aim.com

  • Member
  • Posts: 532
Reply 2 on: Jun 19, 2018
Great answer, keep it coming :)


Missbam101

  • Member
  • Posts: 341
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library